Compounded vs Brand-Name SemaglutideWhat Patients Need to Know
FDA-approved and compounded medications have different regulatory status. Compare the exact product, clinical appropriateness, safety information and actual cost rather than assuming a compounded preparation is equivalent to Ozempic or Wegovy.
What Is Compounded Medication?
Compounding is the practice of creating a customized medication from individual ingredients — typically by a licensed compounding pharmacy — for a specific patient, based on a valid prescription from a licensed provider.
FDA explains that compounded drugs may address a medical need that cannot be met by an approved drug. Compounding is subject to applicable federal and state requirements. Affordability alone should not be presented as a blanket legal exception, and past shortage policies should not be assumed to remain in effect.
Compounded drugs are not FDA-approved. FDA does not review their safety, effectiveness or quality before marketing. Discuss approved alternatives, patient-specific need, dosing instructions and the pharmacy's preparation with your provider.
How They Compare
Brand-Name Semaglutide
Ozempic · Wegovy
Yes — FDA-approved for diabetes (Ozempic) and weight loss (Wegovy)
Novo Nordisk — large pharmaceutical manufacturer
Ask for current product-specific pricing and coverage
FDA-regulated, validated manufacturing processes
Pre-filled auto-injection pen
Potentially covered (Wegovy for weight loss, Ozempic for diabetes)
Subject to brand-name supply/shortage constraints
Compounded Semaglutide
From Licensed Compounding Pharmacies
Not FDA-approved — prepared under USP compounding standards by a licensed pharmacy
State-licensed compounding pharmacies
Varies by preparation and dose; obtain a current quote
USP compounding standards; not FDA-validated manufacturing
Vial and syringe — requires self-injection technique
Generally not covered by insurance
Subject to patient-specific need and current legal requirements
What Compounded Semaglutide Offers
- Not established as equivalent to Ozempic or Wegovy
- Compare actual costs without assuming clinical equivalence
- Prepared by licensed, regulated pharmacies
- Requires a valid prescription from a licensed provider
- Available in custom doses for titration flexibility
- Availability must meet current compounding requirements
What to Know Before Choosing
- Not FDA-approved — manufacturing not validated by FDA
- Requires vial and syringe instead of auto-pen
- Quality depends on the specific compounding pharmacy
- Not covered by insurance
- Patient and provider education on injection technique required
- Regulatory status may change as brand availability improves
Frequently Asked Questions
Is compounded semaglutide safe?
Compounded semaglutide is not FDA-approved. FDA does not review compounded drugs for safety, effectiveness or quality before marketing. A licensed provider and pharmacy must assess patient-specific need and applicable compounding requirements. FDA has reported dosing errors and other safety concerns; approval of Wegovy does not establish the safety of a compounded preparation.
What is the difference between compounded and brand-name semaglutide?
Ozempic and Wegovy are FDA-approved products with specific indications and labeling. Compounded semaglutide is not FDA-approved or established as equivalent to either product. FDA warns that semaglutide salt forms are different active ingredients from the form used in approved drugs. Discuss the exact preparation and its risks with your prescriber and pharmacist.
Why is compounded semaglutide so much cheaper?
Prices vary by product, pharmacy, dose, insurance and eligibility for assistance. A lower price does not establish clinical equivalence or a lawful basis for compounding. Ask for the actual total price and an explanation of the product's regulatory status.
Is compounded semaglutide legal?
Compounding is subject to federal and state requirements that depend on the preparation and circumstances. Do not assume a previous shortage exemption still applies. A prescription alone does not establish compliance. Your prescriber and pharmacy must determine whether a proposed compounded preparation meets current requirements and your medical needs.
Does South Florida Trim Clinic prescribe compounded semaglutide?
South Florida Trim Clinic's licensed providers discuss all medication options with eligible patients, including compounded semaglutide. The specific medication prescribed depends on your clinical evaluation, health history, insurance situation, and your provider's recommendation.
Can I switch from brand-name to compounded semaglutide?
Switching between brand-name and compounded semaglutide is possible under medical supervision. Your provider would evaluate whether switching is clinically appropriate and manage the transition if it is.
Have Questions? Talk to a Provider.
South Florida Trim Clinic's licensed providers walk you through your medication options — brand-name and compounded — without judgment, without pressure, and without upsells.
MEDICAL SOURCES & FURTHER READING
Check the source and its limits. The notes below explain which medical information each reference supports; they are not patient-specific advice or evidence of this clinic's results.
- Understanding the Risks of Compounded Drugs
Compounded drugs are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality before marketing. Compounding may address a patient-specific medical need but carries quality and dosing risks.
- FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss
Addresses compounded semaglutide/tirzepatide dosing errors, salt forms, storage, fraudulent products and why an FDA-approved product should be considered when it meets the patient's medical needs.
Evidence limits: A prescription alone does not establish that a compounded product meets all applicable legal requirements. Do not assume a continuing shortage exemption.
- Wegovy (semaglutide) injection — prescribing information
Sections 1–6 and the Medication Guide cover eligibility, dose escalation, GLP-1 action, gastrointestinal effects, thyroid-tumor warnings, pancreatitis, gallbladder disease, volume depletion and pregnancy precautions.
Evidence limits: This dated label is for FDA-approved Wegovy injection. Follow the current label for your specific product and your prescriber's instructions; it does not establish the safety or effectiveness of a compounded preparation.
RESEARCH & REFERENCES
- Understanding the Risks of Compounded Drugs
U.S. Food and Drug Administration. FDA patient safety information. Web resource; accessed 2026.
Read Understanding the Risks of Compounded Drugs - FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss
U.S. Food and Drug Administration. FDA drug safety information. Web resource; accessed 2026.
Read FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss - Wegovy (semaglutide) injection — prescribing information
U.S. Food and Drug Administration. FDA product labeling. 2025.
Read Wegovy (semaglutide) injection — prescribing information
Compounded drugs are not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness or quality before marketing. Compounded preparations are not established as equivalent to FDA-approved products. Patient-specific need and applicable compounding requirements must be evaluated by the prescriber and pharmacy.
These independent information sources do not endorse, sponsor or affiliate with South Florida Trim Clinic. Education is not a substitute for individualized medical advice. Prescription treatment requires evaluation by an appropriately licensed healthcare provider.